MCW Cancer Center logo

Funding and Grants

Current Funding Opportunities

National Cancer Institute (NCI)

 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01) | Applications due October 5, 2015

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01)

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought.

Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will require transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied.

Applications due October 5, 2015

 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21) | Applications due October 16, 2015

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21)

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought.

Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will require transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied.

Applications due October 16, 2015

National Institutes of Health (NIH)

 Opportunities for Collaborative Research at the NIH Clinical Center (U01) | Applications due April 11, 2016

Opportunities for Collaborative Research at the NIH Clinical Center (U01)

The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets need to reflect the actual needs of the proposed project. The maximum amount available per application is $500,000 direct costs (exclusive of any contract/consortium F&A) per year; this amount includes Clinical Center costs and intramural investigator's costs attributed to the proposed research project. The NIH Clinical Center costs and intramural investigator's costs will not be included in the award paid to the grantee. The scope of the proposed project should determine the project period. The maximum project period is four (4) years.

Applications due April 11, 2016

Department of Defense (DOD)

 Prostate Cancer Research Program | Applications due August and September 2015

Prostate Cancer Research Program

The mission of the FY15 PCRP is to find and fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of men experiencing the impact of the disease. Specifically, the PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; multidisciplinary, synergistic research; translational studies to support the fluid transfer of knowledge between bedside and bench; research on patient survivorship and quality of life; the next generation of prostate cancer investigators through mentored research; and research on disparities in the incidence and mortality of prostate cancer.

Foundations & Organizations

 European Chemical Industry Council (CEFIC) Long-Range Research Initiative (LRI): Database on Carcinogen Dose-Response, Including Information on DNAReactivity, for TTC and Beyond | Applications due September 6, 2015

European Chemical Industry Council (CEFIC) Long-Range Research Initiative (LRI): Database on Carcinogen Dose-Response, Including Information on DNAReactivity, for TTC and Beyond

This Cefic LRI RfP therefore seeks to identify scientists to evaluate studies and other information to build a validated database which will be available to the scientific community for projects, e.g. on TTC, SAR, read-across and other alternative approaches. The second objective of the project is to analyze the potential impact on the TTC concept cancer thresholds when applying current understanding of DNA-reactive versus non-DNA-reactive modes of action and current methods in risk assessment of carcinogens to build distributions and to derive thresholds. The datasets and work done by the ILSI Europe TTC Expert Group up to the date will be made available to the group receiving the grant.

Proposals may be submitted by any European or non-European, for-profit or non-profit organization, public or private entities, such as universities, colleges, laboratories, and contract research organizations; units of national and local governments with the necessary laboratory facilities; and research cooperatives. Collaborations between research institutions are encouraged. Applicants should provide an indication of additional partners and funding opportunities that can be appropriately leveraged as part of their proposal. Partners can include, but are not limited to industry, government/regulatory organizations, research institutes, etc. Statements from potential partners indicating their willingness to participate should be included in the proposal package.

The project will start in early 2016, for a duration of 1.5 years. The budget will be in the order of €190,000. Project costs are expected to be commensurate with project scope and should not exceed the budget indicated in the RfP. Proposals should include funds necessary to complete the full scope and deliverables including direct (staff, travel & living expenses, consumables) and indirect costs (overhead).

Applications due September 6, 2015

 American Urological Association (AUA) Urology Care Foundation: Urology Care Foundation Research Scholars Program | Applications due September 9, 2015

American Urological Association (AUA) Urology Care Foundation: Urology Care Foundation Research Scholars Program

The Research Scholar Program began in 1975 to provide mentored research training awards to early-career investigators, enabling them to ignite their careers and advance urologic research. To be eligible to compete for a 2016 Urology Care Foundation Research Scholar Award, applicants must, by July 1, 2015, be either:

Track 1
Urologists in accredited clinical fellowships (eligible until the end of clinical fellowship); Research scientists who are post-doctoral fellows within five years of completing PhD; or

Track 2
Early-career MD or PhD (or equivalent degree) investigators within the first five years of beginning their faculty positions.

And, for both eligibility tracks:
Be able to commit to no less than one year of performance on the award and no less than 50 percent (for MD or equivalent degree applicants) or 100 percent (for PhD or equivalent degree applicants) of their time on their research projects. Deviation from this requirement will result in disqualification for award consideration or discontinuation of funding, should an award already have been made. MD applicants should clearly state how the research/clinical time will be allocated for the duration of the award.

Awards are $40,000 per year for one or two years of support and require intensive involvement of one or more mentors committed to advancing the development of the Research Scholar. Scholarship stipends will be payable in two annual installments available for distribution on or about July 1 and January 1.

Letter of Intent (Recommended) due July 29, 2015

Applications due September 9, 2015

 National Organization for Rare Disorders, Inc. (NORD): Research Grant Program - Research Seed Money Grant for Pseudomyxoma Peritonei (PMP) | Applications due October 2015 (Date TBA)

National Organization for Rare Disorders, Inc. (NORD): Research Grant Program – Research Seed Money Grant for Pseudomyxoma Peritonei (PMP)

NORD, with funding from the PMP Research Foundation, is accepting applications for scientific research studies and/or clinical research studies related to pseudomyxoma peritonei (PMP). Two 2-year grants, $50,000 per grant, are available.

LOI due July 31, 2015

Full proposal invitations will go out in late August 2015

Applications due in late October 2015; date will be announced

 Cancer Research Institute: Irvington Postdoctoral Fellowships | Applications due October 1, 2015

Cancer Research Institute: Irvington Postdoctoral Fellowships

The program supports qualified individuals who wish to receive training in cancer immunology. The Institute seeks hypothesis driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor must clearly state the potential of the proposed studies to directly impact our understanding of the immune system's role in cancer risk, tumor initiation, progression, metastasis, host response to tumors and/or the treatment of cancer.

Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution. Applicants with five or more years of relevant postdoctoral experience are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation.

The fellowship provides a stipend of $50,000 for the first year, $53,000 for the second year, and $57,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor's discretion to help pay for the fellow's research supplies, travel to scientific meetings, and/or health insurance.

Applications due October 1, 2015

 Leukemia & Lymphoma Society (LLS) Academic Grants: Career Development Program - Special Fellow Award | Applications due October 1, 2015

Leukemia & Lymphoma Society (LLS) Academic Grants: Career Development Program - Special Fellow Award

LLS welcomes applications from qualified investigators who are not US citizens as well as applicants who are performing research outside the USA. Applicants should hold a PhD, MD, DVM, or equivalent degree and have at least two years postdoctoral experience, but less than four and a half years of experience at the time of review (January 1, 2016). Postdoctoral experience begins on the date of the oral thesis defense (or date of degree conferral, whichever comes first), or at the end of clinical education or training. Time spent in the thesis advisor's laboratory following the thesis defense is considered postdoctoral experience. Postdoctoral experience is not defined by the start date in the current laboratory.

The award is for two or three years. The maximum award per year is $65,000 and includes the applicant's salary and fringe benefits, and indirect costs which cannot exceed five percent of the total direct costs. The final value of the award may be limited by the applicant's sponsoring institution's allowable salary range.

Eligibility Phase ends September 1, 2015

Abstract Phase ends September 15, 2015

Applications due October 1, 2015

 Foundation for Women's Cancer: Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher | Nominations due October 28, 2015

Foundation for Women's Cancer: Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher

This prize is awarded to an individual in recognition of his or her outstanding contributions to research to improve the care of women with gynecologic cancer. The selected awardees will have made important contributions to research which have improved the early detection, treatment, or prevention of gynecologic cancer. Individuals can apply for this prize or nominators can propose potential candidates by filling out the application form. The award is $50,000.

Nominations due October 28, 2015

 American Association for Cancer Research (AACR): AACR NextGen Grants for Transformative Cancer Research | Applications due November 23, 2015

American Association for Cancer Research (AACR): AACR NextGen Grants for Transformative Cancer Research

These Grants represent a new AACR funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that, because of its very nature, may not otherwise be funded through existing channels. It is anticipated that the projects funded through this mechanism will have the potential to lead to major breakthroughs in the field.

Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree. AACR membership is required. At the start of the grant term on July 1, 2016, applicants must have held a fulltime, tenure-track appointment at the rank of assistant professor for no more than three years and work at an academic, medical, or research institution anywhere in the world.

The grants provide $450,000 over three years ($150,000 per year) for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students and/or research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

Letter of Intent due August 10, 2015

Applications due November 23, 2015

 Concern Foundation: CONquer canCER Now Award | Applications due December 9, 2015

Concern Foundation: CONquer canCER Now Award

Concern Foundation targets promising individuals and provides critically needed "seed" money for innovative projects. Concern Foundation bridges the gap that currently exists in the scientific research community. Proposals must be hypothesis driven and centered on cancer genetics, cancer epidemiology, or behavioral studies. Grants will only be awarded to independent investigators who are at the start of their scientific career (i.e., junior faculty) and are at the level of Assistant Professor (or equivalent with explanation). Applicant who is PI on an existing R01 or equivalent is not eligible. Applicant who is notified prior to the full Concern grant submission deadline of a clearly fundable score on an R01 or equivalent grant-in-review where he/she is PI is also not eligible.

The total grant amount for a Conquer Cancer Now Award is $60,000 for a period of one year, subject to continued funding of an additional $60,000 for the second year. Consideration for a second year of funding is based on sufficient progress (as determined by the required progress report) and available funds. Concern will not fund overhead costs, indirect costs, or similar fees or charges levied by an institution. Funds are not provided for equipment. All funds are to be distributed only for salaries and supplies directly related to the funded research.

Letter of Intent (Required) due September 9, 2015

Applications due December 9, 2015

 Hope Funds for Cancer Research: Postdoctoral Fellowship | Applications due January 28, 2016

Hope Funds for Cancer Research: Postdoctoral Fellowship

The Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemia, lymphomas and MDS. Candidates must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.

The Hope Funds for Cancer Research is awarding three-year fellowships with a stipend of $48,000 for the first year, $50,000 for the second year, and $52,000 for the third year. A travel grant of $1,500 will be awarded each year to each grantee for the purpose of attending conferences and/or scientific training meetings. All awards and stipends are made to the institution for the support of the designated fellow.

Pre-Application (Required) due September 18, 2015

Invited Applications due January 28, 2016

Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8296
Directions & Maps
© 2015

Page Updated 08/24/2015
Top